Palo Alto, California 94303


Purpose:

The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practice on each patient visit to the ophthalmologist. The investigators' goal is to evaluate whether this method will improve the ability to detect AMD earlier and improve visual outcomes in AMD patients by assigning patient risk categories and having patients come back for follow up based on those categories.


Criteria:

Inclusion Criteria: - Non-exudative age-related macular degeneration Exclusion Criteria: - Exudative age-related macular degeneration


NCT ID:

NCT02422160


Primary Contact:

Theodore Leng, MD
Phone: 650-723-6995


Backup Contact:

N/A


Location Contact:

Palo Alto, California 94303
United States

Theodore Leng, MD
Phone: 650-723-6995

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.